Recombinant bacille Calmette –Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis
Conclusion In this study, we demonstrated that the novel rBCG2 vaccine may be a promising candidate vaccine against M. tuberculosis infection.
Source: Journal of Microbiology, Immunology and Infection - Category: Microbiology Source Type: research
More News: Allergy & Immunology | Microbiology | Pandemics | Study | Tuberculosis | Tuberculosis (BCG) Vaccine | Vaccines